Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02600741 · ClinicalTrials.gov registry record
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
A clinical trial of Schizophrenia, sponsored by Janssen Scientific Affairs.
- Completed
- Registry status
- 296
- Enrollment target
- 20
- Study locations
NCT02600741: Completed study of Schizophrenia, sponsored by Janssen Scientific Affairs.
NCT02600741 is a study of Schizophrenia that has completed, run by Janssen Scientific Affairs. The registered enrollment target is 296 participants, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (36% higher). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02600741, a study of Schizophrenia, has completed, sponsored by Janssen Scientific Affairs.
- COMPLETED
- Registry status
- 296 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary purpose of this study is to evaluate the overall effect of caregivers receiving a study-provided caregiver psycho-education and skills training program on the number of treatment failures (psychiatric hospitalization, psychiatric emergency room (ER) visit, crisis center visit, mobile crisis unit intervention, arrest/incarceration, and suicide or suicide attempt) in patients under their care during a 12 month period.
Primary Outcome
Treatment failure is defined as any of the following: 1. Psychiatric hospitalization 2. Psychiatric emergency room (ER) visit 3. Crisis center visit 4. Mobile crisis unit intervention 5. Arrest/Incarceration 6. Suicide or suicide attempt.
Conditions Studied
Interventions
- DRUG Chlorpromazine
- OTHER Caregiver psycho-education and skills training
- OTHER Caregiver support available at the study site
- DRUG Paliperidone palmitate
- DRUG Droperidol
Study Locations (20)
Florida
- - Lauderdale Lakes
- - Leesburg
- - Miami
- - Orange City
- - Tallahassee
- - West Palm Beach
Illinois
- - Granite City
- - Lombard
- - Springfield
Michigan
- - Ann Arbor
- - Grand Rapids
- - Mount Pleasant
Indiana
- - Bloomington
- - Lawrenceburg
Arizona
- - Bullhead City
California
- - Oceanside
Colorado
- - Denver
Connecticut
- - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 296 participants |
| Start Date | 2015-07-24 |
| Est. Completion | 2018-07-05 |
What the finished NCT02600741 record still lists
NCT02600741 is an observational study that tracks outcomes without assigning an intervention. The registered 296 participants enrollment target is mid-sized for trials with a published cap, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (36% higher).
The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 5 interventions - of which Chlorpromazine is the first listed.
NCT02600741 names 20 study sites across 10 states, led by Florida, Illinois, Michigan.
Frequently Asked Questions
What is clinical trial NCT02600741 about?
NCT02600741 is a clinical study titled "Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)". The primary purpose of this study is to evaluate the overall effect of caregivers receiving a study-provided caregiver psycho-education and skills training program on the number of treatment failures (psychiatric hospitalization, psychiatric emergency room (ER) visit, crisis center visit, mobile cri...
What is the current status of trial NCT02600741?
This trial is currently completed. The enrollment target is 296 participants. The study started on 2015-07-24. Estimated completion is 2018-07-05.
What conditions does trial NCT02600741 study?
This clinical trial studies the following conditions: Schizophrenia.
What interventions are being tested in trial NCT02600741?
The interventions under investigation include: Chlorpromazine (DRUG), Caregiver psycho-education and skills training (OTHER), Caregiver support available at the study site (OTHER), Paliperidone palmitate (DRUG), Droperidol (DRUG).
Who is sponsoring clinical trial NCT02600741?
This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02600741 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02600741's enrollment target sits among peer trials
296 62nd of 315 higher than 254 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Tolerability of MDMA in Schizophrenia
RECRUITING · Phase 1
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
RECRUITING · Phase 4
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05563792 · 296 participants · NA
Options for Pain Management Using Nonpharmacological Strategies
- NCT06828445 · 296 participants · Phase 1
Increasing Affordable Fruits and Vegetables for Families With Food Insecurity
- NCT06920563 · 296 participants · NA
Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education
- NCT06309160 · 297 participants · NA
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI